Diabetes Pay-for-Performance Program Participation and Dialysis Risk in Relation to Educational Attainment: A Retrospective Cohort Study

Overview

Journal Healthcare (Basel)

Specialty Health Services

Date 2023 Nov 24

PMID 37998405

Authors

Yi-Shiun Tsai

Wen-Chen Tsai

Li-Ting Chiu

Pei-Tseng Kung

Affiliations

Soon will be listed here.

Abstract

Pay-for-performance (P4P) programs for diabetes care enable the provision of comprehensive and continuous health care to diabetic patients. However, patient outcomes may be affected by the patient's educational attainment. The present retrospective cohort study aimed to examine the effects of the educational attainment of diabetic patients on participation in a P4P program in Taiwan and the risk of dialysis. The data were obtained from the National Health Insurance Research Database of Taiwan. Patients newly diagnosed with type 2 diabetes mellitus (T2DM) aged 45 years from 2002 to 2015 were enrolled and observed until the end of 2017. The effects of their educational attainment on their participation in a P4P program were examined using the Cox proportional hazards model, while the impact on their risk for dialysis was investigated using the Cox proportional hazards model. The probability of participation in the P4P program was significantly higher in subjects with a junior high school education or above than in those who were illiterate or had only attained an elementary school education. Subjects with higher educational attainment exhibited a lower risk for dialysis. Different educational levels had similar effects on reducing dialysis risk among diabetic participants in the P4P program.

References

Chiou S, Lin H, Yu N, Hseuh H, Lin L, Lin L . An initial assessment of the feasibility and effectiveness of implementing diabetes shared care system in Taiwan--some experiences from I-Lan County. Diabetes Res Clin Pract. 2001; 54 Suppl 1:S67-73. DOI: 10.1016/s0168-8227(01)00311-4. View

McCall D, Sauaia A, Hamman R, Reusch J, Barton P . Are low-income elderly patients at risk for poor diabetes care?. Diabetes Care. 2004; 27(5):1060-5. DOI: 10.2337/diacare.27.5.1060. View

Sandhu S, Wiebe N, Fried L, Tonelli M . Statins for improving renal outcomes: a meta-analysis. J Am Soc Nephrol. 2006; 17(7):2006-16. DOI: 10.1681/ASN.2006010012. View

Afkarian M, Sachs M, Kestenbaum B, Hirsch I, Tuttle K, Himmelfarb J . Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol. 2013; 24(2):302-8. PMC: 3559486. DOI: 10.1681/ASN.2012070718. View

Lin M, Hsu C, Lee C, Cheng S . Effect of a Pay-for-Performance Program on Renal Outcomes Among Patients With Early-Stage Chronic Kidney Disease in Taiwan. Int J Health Policy Manag. 2021; 11(8):1307-1315. PMC: 9808322. DOI: 10.34172/ijhpm.2021.27. View

Selby N, Taal M . An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines. Diabetes Obes Metab. 2020; 22 Suppl 1:3-15. DOI: 10.1111/dom.14007. View

So W, Kong A, Ma R, Ozaki R, Szeto C, Chan N . Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients. Diabetes Care. 2006; 29(9):2046-52. DOI: 10.2337/dc06-0248. View

Brown A, Ettner S, Piette J, Weinberger M, Gregg E, Shapiro M . Socioeconomic position and health among persons with diabetes mellitus: a conceptual framework and review of the literature. Epidemiol Rev. 2004; 26:63-77. DOI: 10.1093/epirev/mxh002. View

Kontopantelis E, Springate D, Ashcroft D, Valderas J, van der Veer S, Reeves D . Associations between exemption and survival outcomes in the UK's primary care pay-for-performance programme: a retrospective cohort study. BMJ Qual Saf. 2015; 25(9):657-70. PMC: 5013124. DOI: 10.1136/bmjqs-2015-004602. View

10.

Muhlfeld A, Spencer M, Hudkins K, Kirk E, LeBoeuf R, Alpers C . Hyperlipidemia aggravates renal disease in B6.ROP Os/+ mice. Kidney Int. 2004; 66(4):1393-402. DOI: 10.1111/j.1523-1755.2004.00854.x. View

11.

Young B, Lin E, Von Korff M, Simon G, Ciechanowski P, Ludman E . Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization. Am J Manag Care. 2008; 14(1):15-23. PMC: 3810070. View

12.

Saydah S, Lochner K . Socioeconomic status and risk of diabetes-related mortality in the U.S. Public Health Rep. 2010; 125(3):377-88. PMC: 2848262. DOI: 10.1177/003335491012500306. View

13.

Chang P, Chien L, Lin Y, Chiou H, Chiu W . Nonadherence of Oral Antihyperglycemic Medication Will Increase Risk of End-Stage Renal Disease. Medicine (Baltimore). 2015; 94(47):e2051. PMC: 5058977. DOI: 10.1097/MD.0000000000002051. View

14.

Pan C, Kung P, Chiu L, Liao Y, Tsai W . Patients with diabetes in pay-for-performance programs have better physician continuity of care and survival. Am J Manag Care. 2017; 23(2):e57-e66. View

15.

Chang R, Lin S, Aron D . A pay-for-performance program in Taiwan improved care for some diabetes patients, but doctors may have excluded sicker ones. Health Aff (Millwood). 2012; 31(1):93-102. DOI: 10.1377/hlthaff.2010.0402. View

16.

Duong V, Lin I, Sorensen K, Pelikan J, Van den Broucke S, Lin Y . Health Literacy in Taiwan: A Population-Based Study. Asia Pac J Public Health. 2015; 27(8):871-80. DOI: 10.1177/1010539515607962. View

17.

Berthoux F, Mohey H, Laurent B, Mariat C, Afiani A, Thibaudin L . Predicting the risk for dialysis or death in IgA nephropathy. J Am Soc Nephrol. 2011; 22(4):752-61. PMC: 3065230. DOI: 10.1681/ASN.2010040355. View

18.

Zeng X, Liu J, Tao S, Hong H, Li Y, Fu P . Associations between socioeconomic status and chronic kidney disease: a meta-analysis. J Epidemiol Community Health. 2018; 72(4):270-279. DOI: 10.1136/jech-2017-209815. View

19.

Doshi T, Smalls B, Williams J, Wolfman T, Egede L . Socioeconomic Status and Cardiovascular Risk Control in Adults With Diabetes. Am J Med Sci. 2016; 352(1):36-44. PMC: 4955859. DOI: 10.1016/j.amjms.2016.03.020. View

20.

Kim S . Educational attainment moderates the associations of diabetes education with health outcomes. Int J Nurs Pract. 2016; 22(5):444-450. DOI: 10.1111/ijn.12454. View